Kynurenate production by cultured human astrocytes

Journal of Neural Transmission

Volumn 110, Issue 1, 2003, Pages 1-14

  Kiss, C ^a   Ceresoli Borroni, G ^a   Guidetti, P ^a   Zielke, C L ^a   Zielke, H R ^a   Schwarcz, R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

7 chlorokynurenic acid; Anticonvulsants; Glia; Neuroprotection; NMDA; 7 nicotinic acetylcholine receptor

Indexed keywords

7 CHLOROKYNURENIC ACID; AMINOOXYACETIC ACID; ANTICONVULSIVE AGENT; GLYCINE; KYNURENIC ACID; KYNURENINE; LEUCINE; N METHYL DEXTRO ASPARTIC ACID; NICOTINIC RECEPTOR; OXALOACETIC ACID; PHENYLALANINE; PYRUVIC ACID; VERATRIDINE;

ARTICLE; ASTROCYTE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DEPOLARIZATION; DOSE RESPONSE; EXTRACELLULAR SPACE; FIBROBLAST; GLIA; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NEUROMODULATION; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STEREOSPECIFICITY; TISSUE HOMOGENATE;

EID: 0037249214     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0770-z     Document Type: Article

References (52)

1. Banker G, Goslin K (1991) Characterizing and staining neuronal cultures. In: Banker G, Goslin K (eds) Culturing nerve cells. MIT Press, Cambridge, pp 75-109
2. Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, Moroni F (2001) Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci 13: 2141-2147
3. Ceresoli-Borroni G, Guidetti P, Schwarcz R (1999) Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats. J Neural Transm 106: 229-242
4. Ceresoli-Borroni G, Kiss C, Guidetti P, Zielke CL, Zielke HR, Schwarcz R (2001) Kynurenic acid production in cultured human astrocytes. Soc Neurosci Abstr 27: 391.5
5. Cozzi A, Carpenedo R, Moroni F (1999) Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4dimethoxy-[-N-4-(nitrophenyl)thiazol-2YL-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J Cereb Blood Flow Metab 19: 771-777
6. Curatolo L, Caccia C, Speciale C, Raimondi L, Cini M, Marconi M, Molinari A, Schwarcz R. (1996) Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes. In: Allegri Filippini G, Costa CVL, Bertazzo A (eds) Recent advances in tryptophan research. Plenum Press, New York, pp 273-276
7. Denizot FLR (1986) Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277
8. Du F, Schmidt W, Okuno E, Kido R, Köhler C, Schwarcz R (1992) Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus. J Comp Neurol 321: 477-487
9. Erhardt S, Hajos M, Lindberg A, Engberg G (2000) Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid. Synapse 37: 104-108
10. Erhardt S, Öberg H, Engberg G (2001a) Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol 363: 21-27
11. Erhardt S, Öberg H, Mathe JM, Engberg G (2001b) Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons. Amino Acids 20: 353-362
12. Gramsbergen JBP, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R (1997) Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem 69: 290-298
13. Guidetti P, Okuno E, Schwarcz R (1997) Characterization of rat brain kynurenine amino-transferases I and II. J Neurosci Res 50: 457-465
14. Guidetti P, Wu H-Q, Schwarcz R (2000) In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity. Exp Neurol 163: 123-130
15. Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78: 842-853
16. Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K (1998) Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Br J Pharmacol 124: 391-399
17. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP (1992) Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fiuid and serum of HIV-1-infected patients. J Neuroimmunol 40: 71-80
18. Heyes MP, Salto K, Major EO, Milstien S, Markey SP, Vickers JH (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Brain 116: 1425-1450
19. Hilmas C, Pereira EFR, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci 21: 7463-7473
20. Hodgkins PS, Schwarcz R (1998) Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate. Eur J Neurosci 10: 1986-1994
21. Hodgkins PS, Wu H-Q, Zielke HR, Schwarcz R (1999) 2-Oxoacids regulate kynurenic acid production in the rat brain: studies in vitro and in vivo. J Neurochem 72: 643-651
22. Kapoor R, Okuno E, Kido R, Kapoor V (1997) Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord. Neuroreport 8: 3619-3623
23. Kiss C, Shepard PD, Schwarcz R (2001) Cortical spreading depression differentially affects cortical NMDA and malonate toxicity in rats: lack of involvement of kynurenic acid. Soc Neurosci Abstr 27: 209.13
24. Knyihar-Csillik E, Okuno E, Vécsei L (1999) Effects of in vivo sodium azide administration on the immunohistochemical localization of kynurenine aminotransferase in the rat brain. Neuroscience 94: 269-277
25. Lee SC, Liu W, Brosnan CF, Dickson DW (1992) Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest 67: 465-476
26. Lee SC, Liu W, Roth PI, Dickson DW, Berman JW, Brosnan CF (1993) Macrophage colony-stimulating factor in human fetal astrocytes and microglia. J Immunol 150: 594-604
27. Lee S-C, Schwarcz R (2001) Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo. Neurosci Lett 304: 185-188
28. Levison SW, McCarthy KD (1991) Astroglia in culture. In: Banker G, Goslin K (eds) Culturing nerve cells. MIT Press, Cambridge, pp 309-336
29. Mason M (1957) Kynurenine transaminase of rat kidney: a study of coenzyme dissociation. J Biol Chem 227: 61-68
30. Moroni F (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375: 87-100
31. Moroni F, Russi P, Lombardi G, Beni M, Carlà V (1988) Presence of kynurenic acid in the mammalian brain. J Neurochem 51: 177-180
32. Oyama VI, Eagle H (1956) Measurement of cell growth in tissue culture with a phenol reagent (Folin-Ciocalteaux). Proc Soc Exp Biol Med 91: 305-307
33. Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM (1997) Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. J Pharmacol Exp Ther 283: 1264-1275
34. Pellicciari R, Natalini B, Costantino G, Mahmoud MR, Mattoli L, Sadeghpour BM, Moroni F, Chiarugi A, Carpenedo R (1994) Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)-alanine, a potent inhibitor of kynurenine-3-hydroxylase. J Med Chem 37: 647-655
35. Poeggeler B, Rassoulpour A, Guidetti P, Wu H-Q, Schwarcz R (1998) Dopaminergic control of kynurenate levels and NMDA toxicity in the developing rat striatum. Dev Neurosci 20: 146-153
36. Roberts RC, Du F, McCarthy K, Okuno E, Schwarcz R (1992) Immunocytochemical localization of kynurenine aminotransferase in the rat striatum. A light and electron microscopic study. J Comp Neurol 326: 82-90
37. Scharfman HE, Hodgkins PS, Lee S-C, Schwarcz R (1999) Quantitative differences in the effects of de novo produced and exogenous kynurenic acid in rat brain slices. Neurosci Lett 274: 111-114
38. 3H]kynurenine as a substrate. Neuroscience 55: 177-184
39. Schwarcz R, Ceresoli-Borroni G, Wu H-Q, Rassoulpour A, Poeggeler B, Hodgkins PS, Guidetti P (1999) Modulation and function of kynurenic acid in the immature rat brain. In: Huether G, Kochen W, Simat TJ, Steinhart H (eds) Tryptophan, serotonin, melatonin - basic aspects and applications. Plenum Press, New York, pp 113-123
40. +-independent transporter of neutral amino acids in astrocytes. J Neurosci 9: 2066-2072
41. Speciale C, Wu H-Q, Gramsbergen JBP, Turski WA, Ungerstedt U, Schwarcz R (1990) Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid. Neurosci Lett 116: 198-203
42. Speciale C, Cini M, Wu H-Q, Salvati P, Schwarcz R, Molinari A, Varasi M (1996) Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents. In: Allegri Filippini G, Costa CVL, Bertazzo A (eds) Recent advances in tryptophan research. Plenum Press, New York, pp 221-227
43. rd edn. John Wiley and Sons, New York, pp 104-169
44. Sternberger N, Sternberger LA (1987) Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci USA 84: 8169-8173
45. Steward O, Torre ER, Tomasulo R, Lothman E (1991) Neuronal activity up-regulates astroglial gene expression. Proc Natl Acad Sci USA 88: 6819-6823
46. Stone TW (2001) Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 64: 185-218
47. Swartz KJ, During MJ, Freese A, Beal MF (1990) Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 10: 2965-2973
48. Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell Jr WO, Schwarcz R (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res 454: 164-169
49. Turski WA, Gramsbergen JBP, Traitler H, Schwarcz R (1989) Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem 52: 1629-1636
50. Vezzani A, Gramsbergen JBP, Speciale C, Schwarcz R (1991) Production of quinolinic acid and kynurenic acid by human glioma. In: Schwarcz R, Young SN, Brown RR (eds) Kynurenine and serotonin pathways: progress in tryptophan research. Plenum Press, New York, pp 691-695
51. Wu H-Q, Schwarcz R (1996) Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain. Brain Res Bull 39: 155-162
52. Wu H-Q, Baran H, Ungerstedt U, Schwarcz R (1992) Kynurenic acid in the quinolinate-lesionedrat hippocampus: studies in vitro and in vivo. Eur J Neurosci 4: 1264-1270